stent

Double Anti platelet aggregation would be sufficient for six months after angioplasty in patients with stable coronary disease NSTSEACS.

Original title:&nbsp;6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug.&nbsp;Reference:&nbsp;Eluting Stents in Patients Nonresistant to Aspirin The Randomized, Multicenter ITALIC Trial. &nbsp;JACC.VOL. 65, NO. 8, 2015 Current recommendations on dual antiplatelet therapy (DAPT) are under review, particularly in acute coronary events due largely to the advent of second-generation stents. This work studied the hypothesis<a href="https://solaci.org/en/2015/03/10/double-anti-platelet-aggregation-would-be-sufficient-for-six-months-after-angioplasty-in-patients-with-stable-coronary-disease-nstseacs/" title="Read more" >...</a>

Invasive evaluation of patients with angina in the absence of coronary lesions

Original title:&nbsp;Invasive Evaluation of Patients with Angina in the Absence of Obstructive Coronary Artery Disease.&nbsp;Reference:&nbsp;Bong-Ki Lee et al.Circulation published online before print February 20, 2015. More than 20% of patients presenting to the cath lab with angina symptoms have no angiographic evidence of coronary artery disease (CAD). Despite a &ldquo;normal&rdquo; angiogram, these patients have persistent<a href="https://solaci.org/en/2015/02/24/invasive-evaluation-of-patients-with-angina-in-the-absence-of-coronary-lesions/" title="Read more" >...</a>

Linear relationship between prognosis and FFR value

Original title:&nbsp;Prognostic Value of Fractional Flow Reserve Linking Physiologic Severity to Clinical Outcomes.&nbsp;Reference:&nbsp;Nils P. Johnson et al. J Am Coll Cardiol 2014;64:1641&ndash;54. Fractional flow reserve (FFR) has become an essential tool for guiding treatment, but its graded relationship to prognosis and its influence by medical treatment vs revascularization, remains unclear. The hypothesis of this study<a href="https://solaci.org/en/2015/02/13/linear-relationship-between-prognosis-and-ffr-value/" title="Read more" >...</a>

Positive result of intraarterial thrombolysis in acute ischemic stroke

Original title:&nbsp;A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke. MR CLEAN Investigators.&nbsp;Reference:&nbsp;O.A. Berkhemer et al. N Engl J Med 2015;372:11-20. In patients undergoing acute ischemic stroke caused by a proximal intracranial artery occlusion, intraarterial endovascular treatment is effective; however, there is no evidence of clinical or functional benefits.&nbsp; This study randomized patients undergoing<a href="https://solaci.org/en/2015/02/10/positive-result-of-intraarterial-thrombolysis-in-acute-ischemic-stroke/" title="Read more" >...</a>

OCT useful to assess non ostial left main lesions

Original title:&nbsp;Frecuency domain optical coherente tomography to assess non-ostial left main artery.&nbsp;Reference:&nbsp;Francesco Burzotta, et al. EuroIntervention 2015;10e1-e8 &nbsp; Optical coherence tomography (OCT) has proved valuable in making decisions and monitoring stents implanted in coronary arteries, but its role in the assessment of left main (LM) lesions remains unclear. The study included 54 patients presenting moderate<a href="https://solaci.org/en/2015/02/09/oct-useful-to-assess-non-ostial-left-main-lesions/" title="Read more" >...</a>

Pretreatment with clopidogrel only for ST elevation AMI patients

Original title:&nbsp;Prognostic impact of clopidogrel pretreatment in patients with acute coronary syndrome managed invasively.&nbsp;Reference:&nbsp;Almendro-Delia M et al. Am J Cardiol. 2015; Epub ahead of print. This study analyzed the ARIAM data including 9621 AMI patients diagnosed with coronary angiography receiving clopidogrel in 49 center between 2002 and 2012. Most patients had STEMI (63%), and most<a href="https://solaci.org/en/2015/02/09/pretreatment-with-clopidogrel-only-for-st-elevation-ami-patients/" title="Read more" >...</a>

Safety and efficacy of DES in saphenous vein bypass graft PCI

Original title:&nbsp;Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.&nbsp;Reference:&nbsp;Aggarwal V et al. J Am Coll Cardiol. 2014;64:1825-1836. &nbsp; This study retrospectively evaluated 2471 receiving after saphenous vein graft (SVG) PCI between October and September 2011. Outcomes were compared using propensity<a href="https://solaci.org/en/2015/02/02/safety-and-efficacy-of-des-in-saphenous-vein-bypass-graft-pci/" title="Read more" >...</a>

Net clinical benefit of bivalirudin in STEMI patients

Original title:&nbsp;Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: Pooled Patient-Level Analysis From the HORIZONS-AMI and EUROMAX Trials.&nbsp;Reference:&nbsp;Stone GW et al. J Am CollCardiol. 2015 Jan 6;65(1):27-38. The HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) that included 3602 STEMI patients undergoing<a href="https://solaci.org/en/2015/01/29/net-clinical-benefit-of-bivalirudin-in-stemi-patients/" title="Read more" >...</a>

Never ending controversy over the duration of post DES dual antiplatelet therapy

Original title:&nbsp;Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month &#8211; Dual Antiplatelet Therapy- The SECURITY Randomized Clinical Trial.&nbsp;Reference:&nbsp;Antonio Colombo et al. J Am CollCardiol. 2014 Nov 18;64(20):2086-97. The optimal duration of dual antiplatelet therapy after second-generation DES implantation is still debated and apparently will remain controversial for some time. The aim of this<a href="https://solaci.org/en/2015/01/15/never-ending-controversy-over-the-duration-of-post-des-dual-antiplatelet-therapy/" title="Read more" >...</a>

Hybrid Revascularization in Multiple Vessels

Original title:&nbsp;Hybrid Revascularization for Multivessel Coronary Artery Disease&nbsp;Reference:&nbsp;Mariuz Gassior, et al. J Am Cardiol Intv 2014;7:1277-83 &nbsp; According to the international guidelines, coronary artery bypass grafting (CABG) continues to be the &ldquo;Gold Standard&rdquo; treatment for multiple vessels diseases. However, second generation DES and the hybrid strategy may eventually change indications. &nbsp; This study randomized 102<a href="https://solaci.org/en/2014/12/18/hybrid-revascularization-in-multiple-vessels/" title="Read more" >...</a>

Top